What Researchers Did
Researchers conducted a review of medical literature using MEDLINE to evaluate hyperbaric oxygen therapy as an adjunct for lower-extremity wound care, particularly in diabetic foot patients.
What They Found
The review identified seven human studies on hyperbaric oxygen therapy for diabetic foot pathology, with five including a control group and two being randomized. These controlled studies involved an average of 28 subjects in the HBO group and 16.2 subjects in the non-HBO control group. Most reviewed reports contained potential biases such as small sample sizes and inadequate evaluation of comorbid conditions.
What This Means for Canadian Patients
Current evidence for hyperbaric oxygen therapy for diabetic foot wounds is limited and often biased, so Canadian patients should discuss treatment options carefully with their healthcare providers. More robust studies are needed to confirm its effectiveness and justify its cost.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This review's findings are limited by the small number of available studies and the methodological biases present in much of the existing literature on hyperbaric oxygen therapy for diabetic foot.